News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

PharmaCyte (PMCB) Making A Comeback



5/18/2017 7:30:55 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
PharmaCyte Biotech, Inc. (OTCMKTS:PMCB), the clinical stage biotechnology company developing medical treatments for cancer and diabetes using the proprietary “Cell-in-a-Box” technology, has recently drawn traders’ attention again. The company is close to an upcoming clinical trial in locally advanced pancreatic cancer. If the company is able to pass this trial, the stock price will become very violent and make an explosive upward move. Some traders are already buying, have a look at the recent upside movements.

Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES